What Is a Clinical Trial? A Patient-Friendly Introduction
When you or someone you love is living with cancer, the phrase clinical trial may come up during a conversation with an oncologist, while reviewing treatment options, or during an online search. It can sound technical or uncertain. At its core, however, a clinical trial is a carefully designed research study involving people. Its purpose is to answer specific questions about health and medical care.
Cancer clinical trials may study an investigational treatment, a new combination or sequence of treatments, a different dose, a diagnostic approach, supportive care, or a way to prevent or detect disease. Every study follows a written plan, called a protocol, that explains who may participate, what will happen during the study, how safety will be monitored, and what information researchers will collect.
Key Takeaways
- A clinical trial is research, not a guarantee that a treatment will help an individual participant.
- Every trial has specific eligibility criteria based on factors such as diagnosis, disease characteristics, prior treatment, health status, laboratory results, and sometimes biomarkers.
- Informed consent is an ongoing process that should help you understand the study before you decide whether to participate.
- Participation is voluntary. You may choose not to participate or may withdraw after enrollment, although you should discuss how to do so safely with the research team.
- Your treating physician and the study team can help you compare a trial with other available options.
Why clinical trials are conducted
Medical progress depends on evidence. Before a new approach becomes part of routine care, researchers must study how it behaves in people. A trial may ask whether an investigational drug can be given safely, what dose should be studied further, whether a treatment shows activity against a particular cancer, or how it compares with an accepted standard.
Trials can also answer questions beyond treatment. Some evaluate imaging or laboratory tests, ways to reduce symptoms, or strategies for improving quality of life. The purpose should be stated clearly in the protocol and explained in the informed consent process.
What protects participants
Clinical research includes multiple safeguards. A protocol is reviewed before a study opens. An Institutional Review Board, or IRB, reviews the study with particular attention to participant rights, safety, and welfare. The research team must follow the approved protocol, document study activities, report required safety information, and protect personal information according to applicable requirements.
Before enrollment, the study team provides an informed consent document and discusses the study with you. This conversation should cover the study's purpose, procedures, reasonably foreseeable risks or discomforts, possible benefits, alternatives, costs or payments when applicable, privacy, whom to contact, and the voluntary nature of participation. Signing the form does not remove your right to ask questions or change your mind.
How eligibility works
Finding a study that looks relevant is only the beginning. Each trial has inclusion criteria, which describe characteristics a participant must have, and exclusion criteria, which identify circumstances that may prevent participation. These criteria are designed to answer the research question and manage risk.
The research team may need medical records, pathology reports, treatment history, recent imaging, laboratory results, a medication list, and biomarker or molecular testing. A preliminary review may suggest that a study deserves closer evaluation, but only protocol-specific screening can determine eligibility. A study's status and available enrollment slots may also change.
What participation may involve
The experience differs by protocol. It may include screening visits, physical examinations, blood tests, imaging, questionnaires, treatment visits, research biopsies, pharmacokinetic blood draws, or follow-up after treatment ends. Some studies require more frequent visits than routine care. Others include randomization, meaning a computer assigns participants to a study group. If placebo is possible, the consent process should explain when and how it may be used.
Ask for a practical description of the schedule. Travel, time away from work, caregiving responsibilities, transportation, and possible costs can matter as much as the scientific details.
How to decide whether a trial is right for you
There is no universal answer. A useful decision brings together the medical facts, your goals, available alternatives, and the demands of participation. Consider asking:
- •What is the main purpose of this study?
- •Why might I be eligible, and what additional screening is required?
- •What is known and not known about the study treatment?
- •What are my other treatment or supportive-care options?
- •What visits, tests, procedures, and time commitments are involved?
- •Who should I contact for symptoms or urgent concerns?
- •How will the study team coordinate with my treating oncologist?
How our FCTG team can help
At Florida Clinical Trials Group, our research team offers an initial clinical trial review for people exploring oncology research options. Our physician investigators and clinical research professionals review the available diagnosis, prior care, and study information to identify protocols that may warrant further evaluation. This is not a determination of eligibility and does not guarantee enrollment or access to an investigational treatment.
Interested in evaluating clinical trial options?
Our medical research team can help review available oncology research options.
Trusted Sources & Further Reading
The information provided by Florida Clinical Trials Group is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Clinical trial availability and eligibility vary by study and participant. Submission of information or completion of an initial review does not guarantee eligibility, enrollment, access to an investigational treatment, safety, or benefit. Patients should discuss all medical care and clinical trial decisions with their treating physician and the qualified research team.
